Similar articles

• Adjuvant mitotane treatment for adrenocortical carcinoma.

  Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A. Terzolo M, et al. N Engl J Med. 2007 Jun 7;356(23):2372-80. doi: 10.1056/NEJMoa063360. N Engl J Med. 2007. PMID: 17554118
• Adjuvant mitotane in adrenocortical carcinoma.

  Dickstein G, Shechner C, Nativ O. Dickstein G, et al. N Engl J Med. 2007 Sep 20;357(12):1257-8; author reply 1259. N Engl J Med. 2007. PMID: 17891838 No abstract available.
• Adjuvant mitotane in adrenocortical carcinoma.

  Lee JE. Lee JE. N Engl J Med. 2007 Sep 20;357(12):1258; author reply 1259. N Engl J Med. 2007. PMID: 17891836 No abstract available.
• Adjunctive treatment of adrenocortical carcinoma.

  Terzolo M, Berruti A. Terzolo M, et al. Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):221-6. doi: 10.1097/MED.0b013e3282fdf4c0. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18438168 Review.
• [Mitotane in the treatment of adrenal carcinoma].

  Sane T. Sane T. Duodecim. 2010;126(17):2040-6. Duodecim. 2010. PMID: 21053521 Review. Finnish.